Cargando…

Campylobacter at the Human–Food Interface: The African Perspective

The foodborne pathogen Campylobacter is a major cause of human gastroenteritis, accounting for an estimated annual 96 million cases worldwide. Assessment of the true burden of Campylobacter in the African context is handicapped by the under-reporting of diarrhoeal incidents and ineffective monitorin...

Descripción completa

Detalles Bibliográficos
Autores principales: Asuming-Bediako, Nikki, Parry-Hanson Kunadu, Angela, Abraham, Sam, Habib, Ihab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631673/
https://www.ncbi.nlm.nih.gov/pubmed/31242594
http://dx.doi.org/10.3390/pathogens8020087
_version_ 1783435572961869824
author Asuming-Bediako, Nikki
Parry-Hanson Kunadu, Angela
Abraham, Sam
Habib, Ihab
author_facet Asuming-Bediako, Nikki
Parry-Hanson Kunadu, Angela
Abraham, Sam
Habib, Ihab
author_sort Asuming-Bediako, Nikki
collection PubMed
description The foodborne pathogen Campylobacter is a major cause of human gastroenteritis, accounting for an estimated annual 96 million cases worldwide. Assessment of the true burden of Campylobacter in the African context is handicapped by the under-reporting of diarrhoeal incidents and ineffective monitoring and surveillance programmes of foodborne illnesses, as well as the minimal attention given to Campylobacter as a causative agent of diarrhoea. The present review of the literature highlights the variability in the reported occurrence of Campylobacter in humans and animal food sources across different countries and regions in Africa. Campylobacter infection is particularly prevalent in the paediatric population and has been isolated from farm animals, particularly poultry, and foods of animal origin. The reported prevalence of Campylobacter in children under the age of five years ranges from 2% in Sudan to 21% in South Africa. In poultry, the prevalence ranges from 14.4% in Ghana to 96% in Algeria. This review also highlights the alarming trend of increased Campylobacter resistance to clinically important antimicrobials, such as ciprofloxacin and erythromycin, in humans and food animals in Africa. This review adds to our understanding of the global epidemiology of Campylobacter at the human–food animal interface, with an emphasis from the African perspective. Interinstitutional and intersectoral collaborations, as well as the adoption of the One Health approach, would be useful in bridging the gaps in the epidemiological knowledge of Campylobacter in Africa.
format Online
Article
Text
id pubmed-6631673
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66316732019-08-19 Campylobacter at the Human–Food Interface: The African Perspective Asuming-Bediako, Nikki Parry-Hanson Kunadu, Angela Abraham, Sam Habib, Ihab Pathogens Review The foodborne pathogen Campylobacter is a major cause of human gastroenteritis, accounting for an estimated annual 96 million cases worldwide. Assessment of the true burden of Campylobacter in the African context is handicapped by the under-reporting of diarrhoeal incidents and ineffective monitoring and surveillance programmes of foodborne illnesses, as well as the minimal attention given to Campylobacter as a causative agent of diarrhoea. The present review of the literature highlights the variability in the reported occurrence of Campylobacter in humans and animal food sources across different countries and regions in Africa. Campylobacter infection is particularly prevalent in the paediatric population and has been isolated from farm animals, particularly poultry, and foods of animal origin. The reported prevalence of Campylobacter in children under the age of five years ranges from 2% in Sudan to 21% in South Africa. In poultry, the prevalence ranges from 14.4% in Ghana to 96% in Algeria. This review also highlights the alarming trend of increased Campylobacter resistance to clinically important antimicrobials, such as ciprofloxacin and erythromycin, in humans and food animals in Africa. This review adds to our understanding of the global epidemiology of Campylobacter at the human–food animal interface, with an emphasis from the African perspective. Interinstitutional and intersectoral collaborations, as well as the adoption of the One Health approach, would be useful in bridging the gaps in the epidemiological knowledge of Campylobacter in Africa. MDPI 2019-06-25 /pmc/articles/PMC6631673/ /pubmed/31242594 http://dx.doi.org/10.3390/pathogens8020087 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Asuming-Bediako, Nikki
Parry-Hanson Kunadu, Angela
Abraham, Sam
Habib, Ihab
Campylobacter at the Human–Food Interface: The African Perspective
title Campylobacter at the Human–Food Interface: The African Perspective
title_full Campylobacter at the Human–Food Interface: The African Perspective
title_fullStr Campylobacter at the Human–Food Interface: The African Perspective
title_full_unstemmed Campylobacter at the Human–Food Interface: The African Perspective
title_short Campylobacter at the Human–Food Interface: The African Perspective
title_sort campylobacter at the human–food interface: the african perspective
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631673/
https://www.ncbi.nlm.nih.gov/pubmed/31242594
http://dx.doi.org/10.3390/pathogens8020087
work_keys_str_mv AT asumingbediakonikki campylobacteratthehumanfoodinterfacetheafricanperspective
AT parryhansonkunaduangela campylobacteratthehumanfoodinterfacetheafricanperspective
AT abrahamsam campylobacteratthehumanfoodinterfacetheafricanperspective
AT habibihab campylobacteratthehumanfoodinterfacetheafricanperspective